Use este identificador para citar ou linkar para este item:
https://observatorio.fm.usp.br/handle/OPI/1617| Título: | Novel glutamatergic agents for major depressive disorder and bipolar disorder |
| Autor(es): | MACHADO-VIEIRA, Rodrigo; IBRAHIM, Lobna; HENTER, Loline D.; ZARATE JR., Carlos A. |
| Parte de: | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, v.100, n.4, Special Issue, p.678-687, 2012 |
| Resumo: | Mood disorders such as major depressive disorder (MDD) and bipolar disorder (BPD) are common, chronic, recurrent mental illnesses that affect the lives and functioning of millions of individuals worldwide. Growing evidence suggests that the glutamatergic system is central to the neurobiology and treatment of these disorders. Here, we review data supporting the involvement of the glutamatergic system in the pathophysiology of mood disorders as well as the efficacy of glutamatergic agents as novel therapeutics. |
| Aparece nas coleções: | Artigos e Materiais de Revistas Científicas - LIM/27 |
Arquivos associados a este item:
| Arquivo | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| art_MACHADO-VIEIRA_Novel_glutamatergic_agents_for_major_depressive_disorder_and_2012.PDF Restricted Access | publishedVersion (English) | 303.46 kB | Adobe PDF | Visualizar/Abrir Solicitar uma cópia |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.